Rhenman & Partners Asset Management
Overview
Rhenman & Partners Asset Management is a Stockholm-based hedge fund specializing in healthcare investments. The firm manages a sector-specific hedge fund registered in Luxembourg, focusing on the healthcare sector. The investment team is supported by a scientific advisory board consisting of medical experts with a global network of researchers and specialists. The firm was founded in 2008 and is based in Stockholm, Sweden. The hedge fund has assets under management of approximately $615 million. The firm focuses on long/short strategies. The firm's headquarters are located at Strandvägen 5a, Stockholm 11451, Sweden. The main fund email is [email protected]. The firm's leadership includes Carl Grevelius (Founder), Henrik Rhenman (Chief Investment Officer), Goran Nordstrom (CEO), and Susanna Urdmark (Portfolio Manager).
Portfolio Companies
Get the full list of 54,000+ investors
Rhenman & Partners Asset Management and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Rhenman & Partners Asset Management
What sectors does Rhenman & Partners Asset Management invest in?
Rhenman & Partners Asset Management invests in Healthcare, Healthcare Services, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Stockholm, Sweden. Rhenman & Partners Asset Management is listed as a hedge fund in the ConnectSafely investor database.
What stage does Rhenman & Partners Asset Management invest at?
Rhenman & Partners Asset Management backs companies at Growth, Late Stage and Pre-IPO, writing cheques of 10M - 50M.
Which regions does Rhenman & Partners Asset Management invest in?
Rhenman & Partners Asset Management invests across Luxembourg and Sweden.
What companies has Rhenman & Partners Asset Management invested in?
Rhenman & Partners Asset Management's portfolio includes AstraZeneca, OncoOne, Orion, Sobi, Swedish Orphan Biovitrum, Hansa Biopharma, SCA and Medivir.
Last updated · Source: ConnectSafely investor database
